McKesson Corporation Cash Flow Statement
MCK / Health Care|15 years of annual SEC 10-K data (FY2012-FY2026)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | $4.8B | $3.3B | -$4.5B | $900.0M | $34.0M | $67.0M | $5.1B | $2.3B | $1.5B | $5.1B | $1.3B | $1.5B | $1.3B | $1.3B |
| Depreciation & Amortization | - | $287.0M | $272.0M | $344.0M | $335.0M | $317.0M | $951.0M | $910.0M | $885.0M | $1.0B | $910.0M | $581.0M | $1.0B | $735.0M | $581.0M |
| Operating Cash Flow | - | $6.2B | $6.1B | $4.5B | $4.4B | $4.0B | $4.3B | $4.7B | $3.7B | $3.1B | $4.7B | $2.5B | $3.1B | $3.1B | $2.5B |
| Capital Expenditures | - | $436.0M | $537.0M | $451.0M | $362.0M | $426.0M | $405.0M | $404.0M | $488.0M | $376.0M | $404.0M | $241.0M | $376.0M | $278.0M | $241.0M |
| Free Cash Flow | - | $5.7B | $5.5B | $4.1B | $4.0B | $3.6B | $3.9B | $4.3B | $3.2B | $2.7B | $4.3B | $2.2B | $2.7B | $2.9B | $2.2B |
| Share Buybacks | - | $4.8B | $3.1B | $742.0M | $1.9B | $1.6B | $1.7B | $2.3B | $1.6B | $450.0M | $2.3B | $1.2B | $450.0M | $130.0M | $1.2B |
| Dividends Paid | - | $381.0M | $345.0M | $276.0M | $294.0M | $292.0M | $262.0M | $253.0M | $244.0M | $227.0M | $253.0M | $194.0M | $227.0M | $214.0M | $194.0M |
| FCF Margin | - | 1.4% | 1.6% | 1.7% | 1.7% | 1.7% | 1.9% | 2.2% | 1.7% | 1.5% | 2.2% | 1.8% | 1.5% | 2.1% | 1.8% |